Rate of Pelvic Organ Prolapse Surgery Among Privately Insured Women in the United States, 2010-2013.

ABSTRACT:

Objective

To analyze utilization of, and payments for, pelvic organ prolapse procedures after the 2011 U.S. Food and Drug Administration (FDA) communication regarding transvaginal mesh.

Methods

This is a retrospective cohort study examining private claims from three insurance providers for inpatient and outpatient prolapse procedures from 2010 to 2013 in the Health Care Cost Institute. Primary outcomes were the change in utilization of prolapse procedures, with and without mesh, before and after the July 2011 FDA communication. Secondary outcomes were the changes in payments and reimbursements for these procedures. Utilization rates and payments were compared using generalized linear models and interrupted time-series analysis.

Results

Utilization of prolapse procedur

SUBMITTER: Sammarco AG 

PROVIDER: S-EPMC5823748 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature